• LAST PRICE
    2.2200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.0100/ 1
  • Ask / Lots
    2.5000/ 1
  • Open / Previous Close
    2.1950 / 2.2200
  • Day Range
    Low 2.1600
    High 2.2824
  • 52 Week Range
    Low 1.5101
    High 4.8400
  • Volume
    17,043
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.23
TimeVolumeEVAX
10:33 ET4002.195
10:54 ET11762.1662
11:18 ET1942.2797
11:21 ET62082.2
11:27 ET1002.2824
12:03 ET16002.2
12:15 ET5002.2
01:49 ET35502.2
02:30 ET15002.21
04:00 ET14662.22
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEVAX
Evaxion Biotech A/S
52.9M
-2.0x
---
United StatesNCNA
NuCana PLC
43.1M
-1.1x
---
United StatesMBIO
Mustang Bio Inc
52.5M
-0.6x
---
United StatesIMNM
Immunome Inc
53.4M
-1.4x
---
United StatesIMUX
Immunic Inc
53.4M
-0.5x
---
United StatesRPHM
Reneo Pharmaceuticals Inc
53.7M
-1.1x
---
As of 2022-12-05

Company Information

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Contact Information

Headquarters
Bredgade 34E, Copenhagen KCOPENHAGEN, Denmark 1260
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$52.9M
Revenue (TTM)
$0.00
Shares Outstanding
23.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.09
Book Value
$1.40
P/E Ratio
-2.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.